Publications by authors named "Gabriele Pecher"

Claim this Profile
C
Chimeric Antigen Receptor (CAR)-NK92 cells effective against glioblastoma, breast- and pancreatic cancer in vitro and in a murine xenograft model of ovarian cancer.
Abdelhadi Boulifa, Alexander Sebastian Franzén, Martin J Raftery, Clarissa Radecke, Gabriele Pecher

Cancer Cell Int· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of beta-(1→3)(1→6)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer cell lines in 2D and 3D cultures.
Abdelhadi Boulifa, Martin J Raftery, Alexander Sebastian Franzén, Clarissa Radecke, Sebastian Stintzing, Gabriele Pecher

BMC Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer.
Alexander Sebastian Franzén, Abdelhadi Boulifa, Clarissa Radecke, Sebastian Stintzing, Martin J Raftery, Gabriele Pecher

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer.
Martin J Raftery, Alexander Sebastian Franzén, Clarissa Radecke, Abdelhadi Boulifa, Günther Schönrich, Gabriele Pecher

Int J Mol Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications for Immunotherapy of Breast Cancer by Understanding the Microenvironment of a Solid Tumor.
Alexander S Franzén, Martin J Raftery, Gabriele Pecher

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering NK Cells for CAR Therapy-Recent Advances in Gene Transfer Methodology.
Paula Schmidt, Martin J Raftery, Gabriele Pecher

Front Immunol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCMV-Mediated Interference of Bortezomib-Induced Apoptosis in Colon Carcinoma Cell Line Caco-2.
Heike Härtel, Janine Theiß, Mohammed O Abdelaziz, Martin J Raftery, Gabriele Pecher

Viruses· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and toxicity of docetaxel combination chemotherapy for advanced squamous cell cancer of the head and neck.
Andreas E Albers, Regina Grabow, Xu Qian, Masen D Jumah, Veit M Hofmann, Gabriele Pecher

Mol Clin Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA Metastatic Colorectal Cancers.
Chengcheng Zhang, Zhe Wang, Zhi Yang, Meiling Wang, Shiqi Li, Gabriele Pecher

Mol Ther· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pattern of the epitope-specific IgG/IgM response against human cytomegalovirus in patients with multiple myeloma.
Elke Bogner, Gabriele Pecher

Clin Vaccine Immunol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yeast-derived beta-(1-3),(1-6)-D-glucan induces up-regulation of CD86 on dectin-1-positive human B-lymphoma cell lines.
Ulf Harnack, Ute Kellermann, Gabriele Pecher

Anticancer Res· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of soluble β-(1-3),(1-6)-D-glucan from Saccharomyces cerevisiae in the murine P388 ascites tumor model.
Ulf Harnack, Klaus Eckert, Gabriele Pecher

In Vivo· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta-(1-3),(1-6)-D-glucan enhances the effect of low-dose cyclophosphamide treatment on A20 lymphoma in mice.
Ulf Harnack, Klaus Eckert, Gabriele Pecher

Anticancer Res· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer cell line YT exerts cytotoxicity against CD86+ myeloma cells.
Ulf Harnack, Heiko Johnen, Gabriele Pecher

Anticancer Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The tumour-targeting human L19-IL2 immunocytokine: preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma.
Manfred Johannsen, Gianluca Spitaleri, Giuseppe Curigliano, Jan Roigas, Steffen Weikert, Gabriele Pecher

Eur J Cancer· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-1 receptor antagonist anakinra enhances tumour growth inhibition in mice receiving peptide vaccination and beta-(1-3),(1-6)-D-glucan.
Ulf Harnack, Heiko Johnen, Gabriele Pecher

Anticancer Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the effect of orally administered soluble beta-(1-3),(1-6)-D-glucan and of G-CSF on the recovery of murine hematopoiesis.
Ulf Harnack, Klaus Eckert, Iduna Fichtner, Gabriele Pecher

In Vivo· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral administration of a soluble 1-3, 1-6 beta-glucan during prophylactic survivin peptide vaccination diminishes growth of a B cell lymphoma in mice.
Ulf Harnack, Klaus Eckert, Iduna Fichtner, Gabriele Pecher

Int Immunopharmacol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of antigen-unloaded immature dendritic cells on antileukemic T-cell cytotoxicity.
Ulf Harnack, Gabriele Pecher

Anticancer Res· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of the CD8+ T cell response against a mucin epitope in patients with breast cancer.
Konrad Kokowski, Ulf Harnack, David C Dorn, Gabriele Pecher

Arch Immunol Ther Exp (Warsz)· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular and humoral immunogenicity of hamster polyomavirus-derived virus-like particles harboring a mucin 1 cytotoxic T-cell epitope.
David C Dorn, Robert Lawatscheck, Aurelija Zvirbliene, Egle Aleksaite, Gabriele Pecher

Viral Immunol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virus-like particles derived from major capsid protein VP1 of different polyomaviruses differ in their ability to induce maturation in human dendritic cells.
Alma Gedvilaite, David C Dorn, Kestutis Sasnauskas, Gabriele Pecher, Aiste Bulavaite

Virology· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific targeting of CD33(+) leukemia cells by a natural killer cell line modified with a chimeric receptor.
Thomas Schirrmann, Gabriele Pecher

Leuk Res· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Down-regulation of the human tumor antigen mucin by gemcitabine on the pancreatic cancer cell line capan-2.
David C Dorn, Ulf Harnack, Gabriele Pecher

Anticancer Res· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial.
Gabriele Pecher, Arnt Häring, Lothar Kaiser, Eckhard Thiel

Cancer Immunol Immunother· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis